The tirzepatide safety profile appears favorable compared to some other GLP-1 medications, though patients with personal or family history of medullary thyroid carcinoma should not use tirzepatide or any GLP-1/GIP agonist
Pruritus was the only adverse event occurring more frequently with obeticholic acid than with placebo
Intravenous administration of superoxide dismutase entrapped in long circulating liposomes II
Acknowledgements The authors would like to thank Henrik Kim Nielsen, Jens Heisterberg, and Karen Hauda (Novo Nordisk A/S, Denmark), and Gina MacNeil (Novo Nordisk Inc, United States) for review of, and input to, the manuscript, as well as Tina stergaard, Sisse Lakner Schmidt, and Michala Cronberg (Novo Nordisk A/S, Denmark) for help with physical stability analyses
Retatrutide as a single agent outperforms cagrilintide as a single agent by a significant margin
Revive your skin with our powerful 30% AHA + 2% BHA Face Serum, expertly crafted to target clogged pores, dark spots, and early signs of ageing